Table 7.
The prevalence of cardiometabolic risk factors in females with estimated glomerular filtration rate ≤ 5th vs. that of ≥95th according to six creatinine-based equations.
| Formula | WHtR ≥ 0.5 | BMI Ow/Ob OITF | BMI Ob IOTF | SBP ≥ 130 or DBP ≥ 85 mm Hg | Glycemia ≥ 5.6 mmol/L | Insulin ≥ 20 μUI/mL | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| eGFR perc. | p | eGFR perc. | p | eGFR perc. | p | eGFR perc. | p | eGFR perc. | p | eGFR perc. | p | |||||||
| ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | |||||||
| Sch-L | 1 | 4 | 0.363 | 9 | 8 | 0.797 | 0 | 2 | 0.495 | 3 | 1 | 0.363 | 2 | 2 | 1.000 | 0 | 4 | 0.118 |
| Leger | 1 | 17 | <0.001 | 1 | 30 | <0.001 | 0 | 11 | 0.001 | 4 | 3 | 1.000 | 2 | 2 | 1.000 | 1 | 9 | 0.016 |
| LM | 1 | 7 | 0.060 | 6 | 11 | 0.290 | 0 | 2 | 0.495 | 4 | 0 | 0.118 | 1 | 2 | 1.000 | 0 | 4 | 0.118 |
| LM-LBM | 1 | 16 | <0.001 | 2 | 29 | <0.001 | 0 | 10 | 0.001 | 3 | 3 | 1.000 | 2 | 2 | 1.000 | 0 | 9 | 0.003 |
| FAS-QH | 2 | 4 | 0.697 | 10 | 6 | 0.286 | 0 | 1 | 1.000 | 3 | 2 | 0.675 | 1 | 2 | 1.000 | 0 | 3 | 0.243 |
| FAS-QA | 0 | 5 | 0.057 | 6 | 9 | 0.579 | 0 | 3 | 0.243 | 4 | 1 | 0.363 | 1 | 1 | 1.000 | 0 | 4 | 0.118 |
| Formula | HDL-C < 1.29 mmol/L | TAG ≥ 1.7 mmol/L | AIP ≥ 0.11 | UA ≥ 340 μmol/L | ACR ≥ 3.5 mg/mmol | CRP > 3 mg/L | ||||||||||||
| eGFR perc | p | eGFR perc | p | eGFR perc | p | eGFR perc | p | eGFR perc | p | eGFR perc | p | |||||||
| ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | ≤5th | ≥95th | |||||||
| Sch-L | 9 | 17 | 0.131 | 4 | 1 | 0.205 | 2 | 2 | 1.000 | 8 | 2 | 0.052 | 2 | 2 | 1.000 | 5 | 8 | 0.555 |
| Leger | 5 | 22 | <0.001 | 2 | 3 | 1.000 | 1 | 5 | 0.205 | 7 | 5 | 0.761 | 4 | 0 | 0.118 | 5 | 14 | 0.041 |
| LM | 9 | 18 | 0.073 | 3 | 1 | 0.618 | 2 | 1 | 1.000 | 9 | 3 | 0.123 | 2 | 2 | 1.000 | 4 | 7 | 0.526 |
| LM-LBM | 5 | 20 | 0.001 | 2 | 3 | 1.000 | 1 | 5 | 0.205 | 8 | 5 | 0.555 | 3 | 0 | 0.243 | 4 | 13 | 0.032 |
| FAS-QH | 7 | 15 | 0.094 | 2 | 1 | 0.614 | 0 | 2 | 0.495 | 4 | 2 | 0.433 | 2 | 2 | 1.000 | 2 | 6 | 0.271 |
| FAS-QA | 8 | 17 | 0.066 | 3 | 1 | 0.618 | 2 | 1 | 1.000 | 10 | 2 | 0.028 | 2 | 1 | 1.000 | 4 | 7 | 0.526 |
The prevalence is given as the number of females presenting the risk factor out of 53/group.
Formulae: Sch-L, Schwartz-Lyon; LM, Lund-Malmo; LM-LMB, Lund-Malmo with lean body mass; FAS-QH, Full-age Spectrum with Q-height; FAS-QA, Full-age Spectrum with Q-age.
WHtR, waist-to-height ratio; BMI, body mass index; ow/ob, overweight/obese; OITF, The International Obesity Taskforce; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; TAG, triacylglycerols; AIP, atherogenic index of plasma; ACR, UA, uric acid; urinary albumin-to-creatinine ratio; CRP, C-reactive protein, significant p is given in bold.